Can Antidepressants Cause Restless Leg Syndrome?

Antidepressants can trigger or worsen restless leg syndrome (RLS), though the risk varies considerably by drug class and individual. A systematic review found that the overall chance of developing or aggravating RLS after starting an antidepressant is uncommon, but a large post-marketing analysis of over 12 million prescriptions reported a fivefold increase in the odds of RLS among antidepressant users compared to the general population. The gap between those two assessments reflects a messy, evolving evidence base where the type of antidepressant, the dose, and the patient’s own biology all shape the outcome.

How Often Does This Actually Happen?

Estimates of antidepressant-related RLS range from vanishingly rare to surprisingly common, depending on how researchers look for it. A multinational pharmacovigilance study tracking nearly 189,000 patients on antidepressants found that doctors attributed RLS to the medication in only about 0.02% of cases overall.¹ That sounds tiny. But pharmacovigilance databases rely on clinicians recognizing and reporting the connection, which many do not. When researchers actively screen antidepressant users for RLS symptoms, the numbers climb. One clinic-based study found RLS in about 15.5% of patients receiving antidepressant treatment, well above general population rates.²

Complicating matters, depression and anxiety themselves raise the risk of RLS even without medication. One study specifically designed to tease apart the drug effect from the disease effect concluded that RLS prevalence did not significantly differ among patients on different antidepressants, and that the mood disorders themselves were the stronger predictor.³ So if you developed RLS around the same time you started an antidepressant, the medication is a plausible culprit but not the only one. The underlying condition you are treating may share some of the blame.

Which Antidepressants Carry the Most Risk?

Not all antidepressants are equal when it comes to leg symptoms. A systematic review looking across multiple studies concluded that among the various classes, mirtazapine stands out as the one most consistently linked to higher rates of both RLS and periodic limb movements during sleep.⁴ The multinational pharmacovigilance data back this up: noradrenergic and specific serotonergic antidepressants like mirtazapine had the highest proportion of RLS cases at 0.07%, roughly seven times the rate seen with SSRIs.¹ A separate post-marketing analysis of over 12 million prescriptions also flagged duloxetine and vilazodone alongside mirtazapine as having the clearest associations with RLS.⁵

Venlafaxine, a serotonin-norepinephrine reuptake inhibitor, also raised concerns in a small study of healthy volunteers, where it increased both RLS symptoms and limb movements during sleep.⁴ The evidence for individual SSRIs is more muddled. Citalopram, fluoxetine, paroxetine, and sertraline have all appeared in case reports, but when researchers have tried to nail down whether any single SSRI or SNRI reliably predicts an RLS diagnosis, the signal has been too weak to draw conclusions.⁶

Tricyclic antidepressants like amitriptyline appear to increase periodic leg movements during sleep, though not necessarily in ways that disturb the sleeper. A controlled study showed that subjects on amitriptyline had significantly more limb movements per hour than those on placebo, but the movements often did not cause arousals.⁷ Whether that qualifies as clinically meaningful RLS or just a lab finding depends on whether you are waking up from it.

Combination therapy seems to amplify the risk. Patients on an SSRI combined with quetiapine, mirtazapine, or trazodone scored roughly five times higher on an RLS severity scale than those on monotherapy.² If you are on multiple psychiatric medications and developing new leg symptoms, the combination rather than any single drug may be the problem.

Why Serotonin Affects Your Legs

The prevailing theory centers on dopamine. RLS is fundamentally a disorder of dopamine signaling in certain brain regions, and drugs that boost serotonin can dampen dopamine activity as a downstream effect. SSRIs and SNRIs flood the brain with serotonin, and that extra serotonin can suppress the dopamine pathways involved in controlling involuntary limb movement.⁸ The result is the uncomfortable creeping, crawling, or aching sensation in the legs that RLS sufferers describe, along with the overwhelming urge to move.

Mirtazapine works through a somewhat different route but arrives at a similar destination. Its antagonism of specific serotonin receptors (5HT2A and 5HT2C) may trigger the release of norepinephrine from the adrenal system, raising serotonin concentrations in the brainstem and worsening RLS symptoms.⁹ This might explain why mirtazapine shows up so consistently in the data despite not being a classical serotonin reuptake inhibitor. It hits the dopamine system from a different angle, but the leg symptoms look the same.

When Symptoms Typically Start

If an antidepressant is going to provoke RLS, you usually do not have to wait long to find out. Research on second-generation antidepressants found that RLS typically appeared during the initial days of treatment.¹⁰ A case report involving a 13-year-old treated with sertraline described symptoms emerging shortly after the drug was started; they resolved once the medication was discontinued.¹¹

This early onset is actually useful. It provides a fairly clean signal: if your legs were fine before the prescription and started bothering you within the first week or two, the temporal link is strong. On the other hand, if RLS appears months into treatment, the connection is less clear-cut, and other factors like worsening iron stores, changes in sleep habits, or progression of the underlying mood disorder deserve scrutiny. Dose increases at a later point can also unmask symptoms, so any change in regimen, not just the initial prescription, is worth tracking.

Telling RLS Apart from Akathisia

A common source of confusion is akathisia, the inner restlessness that many psychiatric medications can cause. Both conditions make you want to move, and both can worsen with certain drugs. But they are different problems with different treatments, and mistaking one for the other leads to the wrong intervention.

RLS is focused in the legs, worsens in the evening and at night, gets better with movement, and often comes with an unpleasant sensory component: tingling, pulling, or a deep ache. Akathisia is a more diffuse sense of agitation. It can involve the whole body, does not follow a circadian pattern, and is driven by an internal sense of restlessness rather than a specific leg sensation. A case series on antidepressant-induced RLS specifically noted that the investigators differentiated RLS from akathisia based on the diurnal variation of symptoms and their concentration in the legs.¹² If your symptoms are worst at bedtime and focused below the knee, that points toward RLS. If you feel wired and unable to sit still throughout the day, akathisia is more likely.

Bupropion as a Safer Alternative

If you need an antidepressant but are prone to RLS, bupropion is the name that comes up most in the literature. Unlike SSRIs and SNRIs, bupropion works primarily by affecting dopamine and norepinephrine rather than serotonin. A randomized controlled trial found that bupropion did not worsen RLS symptoms, leading the researchers to conclude it may be a reasonable choice when an antidepressant is needed in someone who already has RLS.¹³

There is even scattered evidence that bupropion can improve RLS symptoms. One case report described a patient whose RLS resolved within three days of starting bupropion.¹⁴ That said, bupropion is not a dedicated RLS treatment. A head-to-head trial comparing bupropion with ropinirole, a standard RLS medication, showed that ropinirole was better at reducing RLS severity, though bupropion did produce improvement and comparable quality-of-life gains.¹⁵ Bupropion is not the right antidepressant for everyone, but for patients where both depression and RLS need managing, it occupies a useful niche.

Pregnancy Adds Another Layer of Risk

RLS is already more common during pregnancy due to shifting iron levels and hormonal changes. Adding a serotonergic antidepressant on top of that baseline risk appears to make things worse. A study of first-time pregnant women found that serotonergic antidepressant use was associated with roughly an 83% higher prevalence of RLS symptoms in early pregnancy and a 25% increase in mid-pregnancy.¹⁶ Discontinuing antidepressants during pregnancy is not a simple decision and carries its own serious risks, including relapse of depression. But the association is strong enough that pregnant women on these medications should mention new leg symptoms to their provider rather than assuming the discomfort is just a normal part of pregnancy.

Checking Your Iron

Low iron is one of the best-established contributors to RLS in general, and it may make antidepressant-related RLS worse. If a medication pushes your dopamine signaling in the wrong direction and your iron stores are already marginal, the combination can tip you over the symptom threshold faster. A Cochrane review pooling data from eight trials found that iron supplementation meaningfully improved RLS symptom scores compared with placebo.¹⁷

This does not mean you should start iron pills on your own. Iron overload carries its own health risks, and the target is a specific blood marker (ferritin) rather than dietary iron in general. But if you develop RLS on an antidepressant, asking your doctor to check your ferritin level is one of the simplest and most useful first steps. If it comes back low, correcting the deficiency may reduce symptoms enough that you can stay on a medication that otherwise works well for your mood.

What to Do If Your Antidepressant Triggers Leg Symptoms

The worst approach is to stop your antidepressant abruptly on your own. Sudden discontinuation of most antidepressants can trigger withdrawal symptoms that are themselves deeply unpleasant, and the psychiatric condition the drug was treating may rebound. Instead, there are several practical paths to explore with your prescriber:

Dose adjustment: RLS is sometimes dose-dependent. A modest reduction may relieve leg symptoms without sacrificing the antidepressant effect.
Switching drugs: Moving from a serotonergic antidepressant to bupropion removes the mechanism that probably caused the problem. If bupropion is not suitable, some newer antidepressants with different receptor profiles may also carry lower risk.
Iron supplementation: If bloodwork reveals low ferritin, correcting iron stores may help even if the medication stays the same.
Adding a targeted treatment: A case series found that low-dose aripiprazole improved RLS symptoms that had developed under antidepressant treatment, offering a potential add-on option for patients who need to stay on their current antidepressant.¹²

None of these decisions should be made in isolation. RLS is disruptive enough to drive people off medications they genuinely need, and untreated depression is itself a risk factor for poor sleep and worsening physical symptoms. The goal is to find a balance, not to sacrifice mental health for leg comfort or vice versa.

The Role of Periodic Limb Movements

RLS and periodic limb movement disorder (PLMD) often get lumped together, but they are not the same thing. PLMD involves rhythmic leg jerks during sleep that the sleeper may not even be aware of. RLS is the conscious, waking urge to move. Many antidepressants increase periodic limb movements on sleep studies without the patient reporting any subjective leg discomfort. The systematic review on this topic found that sertraline, fluoxetine, and amitriptyline all increased periodic limb movements, but that these movements did not typically disrupt sleep and were therefore unlikely to be clinically meaningful.⁴

This distinction matters because a sleep study showing more limb movements on your antidepressant does not automatically mean you have a problem that needs solving. If you are sleeping well, feeling rested, and your bed partner is not being kicked awake, those extra twitches on a polysomnography readout are a laboratory curiosity rather than a clinical concern. Where periodic limb movements do become relevant is when they fragment your sleep enough to cause daytime fatigue, which is worth mentioning separately from the crawling discomfort of true RLS. The treatment approach differs: RLS demands addressing the dopaminergic imbalance, while asymptomatic periodic limb movements may need no intervention at all.

Children and Adolescents

Most of the research on antidepressant-induced RLS involves adults, so the picture in younger patients is drawn mostly from case reports. One well-documented case involved a 13-year-old girl who developed clear RLS symptoms after starting sertraline for depression. Her symptoms resolved when the medication was stopped, pointing strongly to the drug as the cause.¹¹ Pediatric patients may be less able to articulate what they are feeling, describing the sensations as “growing pains” or simply refusing to go to bed. If a child or teenager recently started an antidepressant and begins complaining about their legs at night or becomes markedly more restless around bedtime, the medication should be considered as a possible contributor. Children already have high baseline rates of iron deficiency, which could compound the pharmacological risk.

1
PubMed Central. Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program
2
Psychiatry and Clinical Psychopharmacology. Is restless legs syndrome related with depression/anxiety disorders or medications used in these disorders? A cross-sectional, clinic-based study
3
PubMed Central. Restless Legs Syndrome: Associated with Major Depressive Disorder and Anxiety Disorder But Not with Antidepressant Use
4
Sleep Medicine Reviews. The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review
5
Sleep Medicine Reviews. Clinical Review Periodic limb movements in sleep in patients using antidepressants
6
PubMed. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome
7
PubMed. The influence of the tricyclic antidepressant amitriptyline on periodic limb movements during sleep
8
Clinical Psychopharmacology and Neuroscience. Potential Effect of Vortioxetine on Restless Leg Syndrome
9
PubMed Central. Restless Leg Syndrome and Its Relation to Mirtazapine: A Case Report
10
Journal of Psychiatric Research. Restless legs syndrome as side effect of second generation antidepressants
11
PubMed Central. Development of Restless Leg Syndrome in a Pediatric Patient Treated with Sertraline
12
Clinical Psychopharmacology and Neuroscience. Aripiprazole Has Potential Efficacy for Antidepressant-induced Restless Legs Syndrome: A Case Series
13
PubMed. Bupropion and restless legs syndrome: a randomized controlled trial
14
PubMed. Bupropion as a possible treatment option for restless legs syndrome
15
PubMed Central. A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis-Ekbom disease)
16
SLEEP. 0692 Medication Use and Restless Legs Syndrome in Pregnancy Among Nulliparous Women
17
PubMed Central. Iron for the treatment of restless legs syndrome